Development Advice for Gene Therapy Products
October 24, 2018 | 1pm ET / 10am PT | Rho

It has been and big year for gene therapy. This webinar will review Commissioner Gottlieb’s statement, provide an overview of the six guidance documents, and discuss the implications for development of new gene therapy products from the perspective of regulatory strategy, clinical development, pharmacology/toxicology considerations, and CMC development.

Critical Insights for Oncology Drug Development in Japan and Asia
October 2, 2018 | 11am ET / 8am PT | CMIC

Considering oncology drug development and clinical trial for Asia market? Join the experts from CMIC Group, the largest CRO in Japan, to learn the insights on how to start your early oncology drug development and ensure clinical trial success. Register now!

Conquering Compliance: Insights for Commercial Teams in the Medical Device Industry
September 27, 2018 | 2pm ET / 11am PT | Seismic

What can sales and marketing teams do to address the issue of compliance? Learn why compliance is so important to sales and marketing teams in the medical device industry, how digital transformation and sales enablement can help sales and marketing teams, and more. Register now!

Ex Vivo/In Vivo Platforms for Translational Oncology Research
September 26, 2018 | 11am ET / 8am PT | Champions Oncology

Champions Oncology PDX models are the most highly-characterized, clinically-relevant cohorts of PDX models to optimally predict success and accelerate the drug development process. This webinar will provide an overview of the various unique and advanced translational tools that are offered by Champions oncology in an in vivo and ex vivo setting. 

1 Year Later – Why did Thermo Fisher Scientific acquire Patheon?
September 17, 2018 | 11am ET / 8am PT | Patheon

One year ago, Thermo Fisher Scientific completed the acquisition of Patheon, creating the world’s most comprehensive and sophisticated end-to-end CDMO partner. But what does that mean to the industry today? 

Navigating Patient Reported Outcomes: Foundational Elements and Recent Trends
September 13, 2018 | 12pm ET / 9am PT | Cardinal Health

Navigating patient-reported outcomes (PROs) such as unobservable symptoms, treatment satisfaction, quality of life, and treatment adherence is a critical component of a patient centric healthcare system. Join our experts in the first of a three-part webinar series on PROs, as they provide insight on the foundational elements of PROs and recent regulatory trends. Register now!

A Lipid Nanoparticle Quantitative Systems Pharmacology Case Study
September 12, 2018 | Applied Biomath

This webinar will present a quantitative systems pharmacology case study which assesses a Lipid Nanoparticle to treat Crigler-Najjar Syndrome Type 1. Learn how the model was used to support translation from preclinical to clinical trials as well as first-in-human dosing.

Real-World Evidence in the Cloud: How Technology is Revealing the Big Picture in Pharma
Amazon Web Services

Life science companies are responding with Real World Evidence (RWE) programs to capture data from clinical through post-market activities from a variety of sources. Learn how the centralization of data assets enables organizational intelligence by equipping companies to understand the needs of patients and other stakeholders, and how their products can meet them.  Download this Whitepaper!

Evolving Approaches to Drug Value Assessment in Global Markets
Health Strategies Group

The window of market exclusivity continues to narrow dramatically in the global marketplace. Given this demanding environment, your global market access team faces increasing urgency to get the value proposition right at the time of launch. Learn how and why assessment of drug value is changing, and implications for global market access. Download this Whitepaper!


Translate Your Strategy Into An Actionable Commercial Plan
Alexander Group

Is your go-to-customer model positioning you for success? Recent Alexander Group research explores important industry trends that can help you plan for 2019. Learn the top commercial investment strategies and how they can lead to 3x the industry average growth rate. Download Now!

Understanding New Drug Applications (NDAs)
Recorded on August 14, 2018 | Rho

This webinar will help you understand what is involved in an NDA including regulatory strategy, data integration and readiness, and electronic publishing, and provide tips that can help you avoid common pitfalls in the submissions process.

Putting The Researcher In The Driver’s Seat: The Race To Connecting Workflow Tools in Life Sciences Research
Reprints Desk

There is a remarkable scientific research revolution underway: technology that facilitates highly personalized research workflows is being developed and will soon become mainstream. Far more valuable than simply presenting information, personalized access tools will put the researcher in the driver’s seat, making the best of available content and data by pinpointing to what’s important. Download Now!


Discover, develop and deploy; this is a very methodical approach for any solution design, yet it is rarely followed in the creation of patient support programs.  This three-part process, or 3-D, is imperative to launch a suite of services that is right for your product and your patients. Download Now!

Executive Summary
Executive Summary: Investigator Site Payments Strategy Survey

As the number of clinical trials increases so does the complexity and number of US and global sites needed to foster trial success. Read what was discovered after a survey on current site payment practices, how these practices are measured, what process improvement initiatives are currently being explored, what are some of the barriers to change, and what site payment trends will occur over the next five years. Download it now!

Paid Marketplace

Develop a basic understanding of principles and concepts of bioavailability of oral drugs. This course, designed for scientists involved in pharmaceutical drug development, will simplify the concepts of bioavailability and how to manage biopharmaceutical challenges, and identify why it is an important factor in optimal therapies for patients. Enroll Now!

Getting to First-in-Human Clinical Trials: A Make-or-Break Milestone for Small Biopharmas
Patheon, part of Thermo Fisher Scientific

“Faster and better” has become the mantra for biopharmaceutical companies as they face intense pressure to get therapies to market faster. Quickly proving efficacy in first-in-human (FIH) trials is a make-or-break milestone for these cash-strapped companies whose hopes hinge upon one or two molecules. Read how CDMOs are responding to this pressure. 

Avoid Enrollment Pitfalls: Find Your Best-fit Clinical Trial Sites

Selecting the right sites is the most crucial decision you’ll make in your next clinical trial, and the single most important factor to consider in selecting a site is whether or not it can meet its enrollment goals. So, how do sponsors determine the best-fit sites for their studies?  Download the whitepaper to find out.

The State of Sales Enablement in the Healthcare Industry

Take this quick 10 minute survey on on the state of sales enablement in the healthcare industry. A $5 Amazon Gift Card will be sent to the first 50 qualified respondents. Complete the survey now!

New Findings from the Veeva 2018 Unified Clinical Operations Survey
July 25, 2018 | 12pm ET / 9am PT | Veeva

Hear new results from one of the industry's largest, global clinical operations surveys, the Veeva 2018 Unified Clinical Operations Survey. The Veeva 2018 Unified Clinical Operations Survey examines the industry’s progress toward a unified clinical operating environment.

Industry Report: Findings from the 2018 Unified Clinical Operations Survey

Learn why unifying clinical applications is an industrywide priority for clinical operations leaders. Read the report.

Building the Business Case for RIM Transformation

Ready to modernize your RIM environment? Secure buy-in with these tips. Download Today!

Removing Roadblocks: A Strategic Map to Improving the Customer Experience
Recorded on June 28, 2018 | Seismic

To elevate the customer experience in real-time, Pharma organizations must deploy strategies that cut through the market noise and engage customers with a higher degree of customization. Learn the right tools to implement that enable commercial teams to be more collaborative, scalable, and knowledgeable. Register now!

PwC Health Research Institute's Medical Cost Trend: Behind the Numbers 2019
Recorded on June 26, 2018 | PwC

Where is the medical cost trend headed in 2019? PwC’s Health Research Institute (HRI) annually projects the growth of medical costs in the employer insurance market for the coming year and identifies the leading factors expected to impact the trend. Uncover the factors impacting medical cost trend - from provider megamergers and physician employment trends to health advocacy and the increasing customer centricity of healthcare - and what it means for providers, payers, pharma/life sciences companies and employers. Register now!

The Changing Landscape of Real-World Evidence and its Impact on Clinical Research
Thursday, June 21, 2018 | 11am ET / 8am PT | TriNetX

Researchers are encumbered with a plethora of disparate data and analytic tools. These assets pose several challenges which need to be overcome to ensure they satisfy their intended purpose. 

Join this webinar to learn how real-time, self-service access to longitudinal patient data is changing the way researchers evaluate treatment effectiveness, safety, protocol design, and more. Register now.

Fast Track your Early Clinical Development Lifecycle
Recorded on June 20, 2018 | Medidata Solutions

Sponsors continually search for opportunities to contain early stage trial costs while addressing increasingly unique study needs and pressure to shorten timelines. Explore how to simplify and streamline Phase I and IIa study execution through clinical technology. Join this webinar and discover how early-stage solutions can give you the competitive edge you need to accelerate your clinical development lifecycle. Register now!

Demystifying Performance Testing: Strategies to Qualify Combination Products
Recorded on June 18, 2018 | West Pharmaceutical Services, Inc.

What’s the best strategy to create a holistic syringe-based combination product performance testing program? Start with the fundamentals - ISO and USP considerations. Join West packaging and performance experts as they explain how fit-for-purpose syringe-based combination product packaging involves holistic consideration and testing. Register now!

Handling Suspected Fraud and Data Fabrication in Clinical Studies
June 13, 2018 | 1pm ET / 10am PT | Rho

Fraud and fabrication is no laughing matter in the realm of clinical trials.

This webinar will outline the ways in which sponsors and CROs can remain diligent by being aware of signs of possible fraud and fabricated data throughout the course of the study.

Implementing a Proactive Approach to Risk Management

A solid RBM plan will not only help you comply with the ICH guidelines, but will help you mitigate risks which could ultimately delay your trials and increase costs. Download today!

Overcome Data Chaos with QuartzBio: Turn Biomarker Data Sets into Actionable Insights
Recorded on May 29, 2018 | Precision for Medicine

Discover how evaluating biomarkers in early-phase studies leverages advanced technologies and seamlessly transform millions of data points into actionable insights. This webinar will explore biomarker data trends and challenges, share real-world case studies, and dive into practical technology-based solutions that can be readily implemented. Register now!

Show Preview
Your oncology trial is complex. Get specialized expertise, end to end.
Precision for Medicine, Oncology and Rare Disease

The first precision medicine CRO designed specifically for oncology and rare disease, Precision unifies translational science expertise and unparalleled clinical operations to create a more efficient process, deeper data, and an accelerated development pathway for novel treatments.


With 1200+ experts worldwide, one core team delivers


  • Clinical development planning
  • Expedited study start up enabled by Precision’s Oncology Site Network
  • Personalized clinical trial execution services
  • Specialty labs services and coordination
  • Robust biometrics teams and services


Schedule a meeting with our experts at ASCO, Booth 24146, and visit our website

RBM: The Missing Link Bringing Drugs to Market Efficiently
Recorded on May 23, 2018 | Medidata Solutions

How is ICH GCP E6 R2 making it easier for patients to receive the right treatment at the right time? This webinar will explore the essential elements of RBM, straight from the drawing board of ICH E6 R2 working group, and RBM's role in addressing complexities in oncology clinical trials with a roadmap to get ahead. Register now!

Best Practices to Meet Financial Objectives When Selecting an Investigator Payments Partner
Recorded on May 16, 2018 | Bioclinica

What criteria is of most value when determining the value of in-house vs. outsourced site payments strategies? Attend this webinar and discover what best practices sponsors and CROs should follow when evaluating a current or future investigator payments partner. Register now!

505(b)(2) Strategy for Biotech Execs: Positioning Your Products for Success
May 9, 2018 | 11am ET / 8am PT | Camargo

This webinar will benefit Biotech executives interested in aligning their products for success via early strategy for 505(b)(2) drug development. Register Now

Paid Marketplace
AACR Annual Meeting 2018
Charles River

When it comes to choosing a partner, who do you want on your team? How about a provider with 52 patents, 17 candidates and work on 80% of the oncology therapies approved in 2017? Our next success can be yours. Choose Charles River to guide your therapy through the complex path to clinic with proven expertise and the industry’s most comprehensive portfolio. Learn More.

Back from the dead: FierceBiotech Radio at the Battle of the Biotech Bands
FierceBiotech Radio

Here’s a special “risen-from-the-grave” episode covering this year’s Battle of the Biotech Bands, an (almost) annual Boston tradition which sees bands from the biotech industry compete to win prize money for charity.  Download the episode on iTunes or Stitcher, or listen here

Considering an eTMF Solution? Industry Research Reveals the Top Benefits

The largest survey of TMF owners reveals drivers and trends in improving inspection readiness and shortening trial time. Read more.

FierceBiotech Radio on GSK's CEO shakeup, Lilly's Alzheimer's uncertainty, and Valeant's latest disaster
FierceBiotech Radio

FiercePharma's Eric Palmer and FierceBiotech's Damian Garde discuss the pending retirement of GlaxoSmithKline CEO Andrew Witty, Eli Lilly's bold decision with a big Alzheimer's trial and Valeant Pharmaceuticals' rough week.

Download the episode on iTunes or Stitcher, or listen here.

FierceBiotech Radio on the FDA's new boss, Sanofi's latest shortcut, and a little 'financial innovation'
FierceBiotech Radio

FiercePharma's Eric Palmer and FierceBiotech's Damian Garde discuss the confirmation of Robert Califf as the next FDA commissioner, Sanofi's efforts to undercut Novo Nordisk in diabetes, and a novel approach to regulating drug costs. Download the episode on iTunes or Stitcher, or listen here--and be sure to subscribe

Pharma's TV blitz, biotech's IPO trickle, and the M&A future of Intercept Pharmaceuticals

FiercePharma's Eric Palmer and FierceBiotech's Damian Garde discuss the rise of TV ads for specialty drugs, signs of life in the biotech IPO scene, and the case for Intercept Pharmaceuticals as a buyout target.  Download the episode on iTunes or Stitcher, or listen here--and be sure to subscribe.

Pharma's day on the Hill, biotech's paucity of M&A, and the gathering storm of biosimilars
FierceBiotech Radio

FiercePharma's Eric Palmer and FierceBiotech's Damian Garde discuss a bizarre congressional hearing, how biotech's slump affects the buyout climate, and a major development in the world of biosimilars.

Download the episode on iTunes or Stitcher, or listen here--and be sure to subscribe. Let us know what you think by dropping a line to [email protected]

Gilead's wide-open future, biotech's long winter, and Sanofi's ongoing makeover
FierceBiotech Radio

FiercePharma's Eric Palmer and FierceBiotech's Damian Garde discuss the future of Gilead Sciences, biotech's continued slump on Wall Street, and the latest move in Sanofi's efforts to right the ship.

Download the episode on iTunes or Stitcher, or listen here--and be sure to subscribe. Let us know what you think by dropping a line to [email protected]

Shire's byzantine Baxalta pursuit, biotech's pragmatic winter and Valeant's CEO shakeup
FierceBiotech Radio

Fierce editors discuss Shire's increasingly complicated ambition to acquire Baxalta, the changing climate of biotech venture capital and the future of Valeant Pharmaceuticals.  Click here to listen now.